Neutralization of Haemorrhagic Activity of Viper Venoms by 1-(3-Dimethylaminopropyl)-1-(4-Fluorophenyl)-3-Oxo-1,3-Dihydroisobenzofuran-5-Carbonitrile

Basic and Clinical Pharmacology and Toxicology

Volumn 109, Issue 4, 2011, Pages 292-299

  Sunitha, Kabburalli ^a   Hemshekhar, Mahadevappa ^a   Gaonkar, Santosh Laxman ^a   Sebastin Santhosh, Martin ^a   Suresh Kumar, Muthuvel ^b   Basappa, S ^c   Priya, Babu Shubha ^a   Kemparaju, Kempaiah ^a   Rangappa, Kanchugarakoppal Subbegowda ^a   Nanjunda Swamy, Shivananju ^d   Girish, Kesturu Subbaiah ^a  

^a UNIVERSITY OF MYSORE   (India)

^b PONDICHERRY UNIVERSITY   (India)

^c BANGALORE UNIVERSITY   (India)

^d SRI JAYACHAMARAJENDRA COLLEGE OF ENGINEERING   (India)

Author keywords

[No Author keywords available]

Indexed keywords

1 (3 DIMETHYLAMINOPROPYL) 1 (4 FLUOROPHENYL) 3 OXO 1,3 DIHYDROISOBENZOFURAN 5 CARBONITRILE; ANTITOXIN; PHOSPHOLIPASE A2; UNCLASSIFIED DRUG; VIPER VENOM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; CONTROLLED STUDY; CROTALUS ATROX; DOSE RESPONSE; DRUG ACTIVITY; DRUG PROTEIN BINDING; ECHIS CARINATUS; ECHIS CARINATUS LEAKEYI; ECHIS CARINATUS SOCHUREKI; ECHIS OCELATUS; ENVENOMATION; ENZYME INHIBITION; HISTOPATHOLOGY; MALE; MOLECULAR MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SNAKE; STRUCTURE ACTIVITY RELATION;

ANIMALS; BENZOFURANS; CITALOPRAM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; ERYTHROCYTES; HEMOLYSIS; HEMORRHAGE; HUMANS; MALE; MICE; PHOSPHOLIPASES A; PROTEIN BINDING; SKIN; VIPER VENOMS;

CROTALUS ATROX; ECHIS; ECHIS CARINATUS; ECHIS CARINATUS SOCHUREKI; ECHIS PYRAMIDUM LEAKEYI; VIPERINAE;

EID: 80052658687     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2011.00725.x     Document Type: Article

References (31)

1. Tan NH, Ponnudurai GA. Comparative study of the biological properties of venoms of some old world vipers (subfamily viperinae). Int J Biochem 1992;24:331-6.
2. Gutierrez JM, Rucavado A. Snake venom metalloproteinases: their role in the pathogenesis of local tissue damage. Biochimie 2000;82:841-50.
3. Baldo C, Jamora C, Yamanouye N, Zorn TM, Moura-da-Silva AM. Mechanisms of vascular damage by hemorrhagic snake venom metalloproteinases: tissue distribution and in situ hydrolysis. PLoS Negl Trop Dis 2010;4:e727.
4. Moura-da-Silva AM, Butera D, Tanjoni I. Importance of snake venom metalloproteinases in cell biology: effects on platelets, inflammatory and endothelial cells. Curr Pharm Des 2007;13:2893-2905.
5. Anai K, Sugiki M, Yoshida E, Maruyama M. Neutralization of a snake venom haemorrhagic metalloproteinase prevents coagulopathy after subcutaneous injection of Bothrops jararaca venom in rats. Toxicon 2002;40:63-8.
6. Lalloo DG, Theakston RDG. Snake antivenoms. J Toxin 2003;41:277-90.
7. Gutierrez JM, Lomonte B, Leon G, Rucavado A, Chaves F, Angulo Y. Trends in snakebite envenomation therapy: scientific, technological and public health considerations. Curr Pharm Des 2007;13:2935-50.
8. Rucavado A, Escalante T, Gutierrez JM. Effect of the metalloproteinase inhibitor batimastat in the systemic toxicity induced by Bothrops asper snake venom: understanding the role of metalloproteinases in envenomation. Toxicon 2004;43:417-24.
9. Howes JM, Theakston RDG, Laing GD. Neutralization of the haemorrhagic activities of viperine snake venoms and venom metalloproteinases using synthetic peptide inhibitors and chelators. Toxicon 2007;49:734-9.
10. Borkow G, Gutiérrez JM, Ovadia M. Inhibition of the hemorrhagic activity of Bothrops asper venom by a novel neutralizing mixture. Toxicon 1997;35:865-77.
11. da Silva JO, Fernandes RS, Ticli FK, Oliveira CZ, Mazzi MV, Franco JJ et al. Triterpenoid saponins, new metalloprotease snake venom inhibitors isolated from Pentaclethra macroloba. Toxicon 2007;50:283-91.
12. Rucavado A, Henríquez M, García J, Gutiérrez JM. Assessment of metalloproteinase inhibitors clodronate and doxycycline in the neutralization of hemorrhage and coagulopathy induced by Bothrops asper snake venom. Toxicon 2008;52:754-9.
13. Soares AM, Ticli FK, Marcussi S, Lourenço MV, Janu'ario AH, Sampaio SV et al. Medicinal plants with inhibitory properties against snake venoms. Curr Med Chem 2005;12:2625-41.
14. Gomes A, Da A, Chatterjee I, Sarkhel S, Mishra R, Mukherjee S et al. Herbs and herbal constituents active against snake bite. Indian J Exp Biol 2010;48:865-78.
15. Sindrup SH, Bjerre U, Dejgaard A, Brøsen K, Aaes-Jørgensen T, Gram LF. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther 1992;52:547-52.
16. Atmaca M, Kuloglu M, Tezcan E, Semercioz A. The efficacy of citalopram in the treatment of premature ejaculation (prem-e): a placebo-controlled study. Int J Impot Res 2002;14:502-5.
17. Petersen H, Dancer R. A method for the preparation of citalopram comprising reaction of a compound of formula 5-aminomethyl-1-(3-dimethylamino-propyl)-1-(4-fluoro-phenyl)-1, 3-dihydro-isobenzofuran with an oxidising agent to prepare citalopram. PCT Int Appl10/291174, 2001.
18. Boman HG, Kaletta U. Chromatography of rattlesnake venom; a separation of three phosphodiesterases. Biochim Biophys Acta 1957;24:619-31.
19. Kondo H, Kondo S, Ikezawa H, Muruta R, Ohsaka A. Studies on the quantitative method for determination of haemorrhagic activity of Habu snake venom. Jpn J Med Sci Biol 1960;13:43-51.
20. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK et al. Automated docking using a Lamarckian Genetic Algorithm and empirical binding free energy function. J Comput Chem 1998;19:1639-62.
21. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the folin-phenol reagent. J Biol Chem 1951;193:265-75.
22. Gutiérrez JM, Rucavado A, Escalante T, Díaz C. Hemorrhage induced by snake venom metalloproteinases: biochemical and biophysical mechanisms involved in microvessel damage. Toxicon 2005;45:997-1011.
23. Oliveira AK, Paes Leme AF, Asega AF, Camargo AC, Fox JW, Serrano SM. New insights into the structural elements involved in the skin haemorrhage induced by snake venom metalloproteinases. Thromb Haemost 2010;104:485-97.
24. Gutie'rrez JM, Rucavado A, Ovadia M. Metalloproteinase inhibitors in snakebite envenomations. Drug Discov Today 1999;4:532-33.
25. Leanpolchareanchai J, Pithayanukul P, Bavovada R, Saparpakorn P. Molecular docking studies and anti-enzymatic activities of Thai mango seed kernel extract against snake venoms. Molecules 2009;14:1404-22.
26. Kini RM. Venom Phospholipase A2 Enzymes: Structure, Function and Mechanism. J Wiley Publishers, New York, 1997.
27. Lizano S, Domont G, Perales J. Natural phospholipase A2 myotoxin inhibitor proteins from snakes, mammals and plants. Toxicon 2003;42:963-77.
28. Souza AD, Rodrigues-Filho E, Souza AQ, Pereira JO, Calgarotto AK, Maso V et al. Koninginins, phospholipase A2 inhibitors from endophytic fungus Trichoderma koningii. Toxicon 2008;51:240-50.
29. Thimmegowda NR, Dharmappa KK, Kumar CS, Sadashiva MP, Sathish AD, Nanda BL et al. Synthesis and evaluation of tricyclic dipyrido diazepinone derivatives as inhibitors of secretory phospholipase A2 with anti-inflammatory activity. Curr Top Med Chem 2007;7:811-20.
30. Campos VR, Abreu PA, Castro HC, Rodrigues CR, Jordão AK, Ferreira VF et al. Synthesis, biological, and theoretical evaluations of new 1, 2, 3-triazoles against the hemolytic profile of the Lachesis muta snake venom. Bioorg Med Chem 2009;17:7429-34.
31. Oruch R, Hodneland E, Pryme IF, Holmsen H. In thrombin stimulated human platelets Citalopram, Promethazine, Risperidone, and Ziprasidone, but not Diazepam, may exert their pharmacological effects also through intercalation in membrane phospholipids in a receptor-independent manner. J Chem Biol 2009;2:89-103.